TY - JOUR
T1 - The daily association between positive affect and psychotic experiences in individuals along the early stages of the psychosis continuum
AU - van der Tuin, Sara
AU - Staines, Lorna
AU - Morosan, Larisa
AU - Raposo de Almeida, Esdras
AU - van den Berg, David
AU - Booij, Sanne H
AU - Oldehinkel, Albertine J
AU - Wigman, Johanna T W
N1 - Copyright © 2024 van der Tuin, Staines, Morosan, Raposo de Almeida, van den Berg, Booij, Oldehinkel and Wigman.
PY - 2024/8/29
Y1 - 2024/8/29
N2 - INTRODUCTION: Psychosis often develops gradually along a continuum of severity. Little is known about the role of protective factors such as positive affect (PA) in the development of psychotic experiences (PEs). This study investigated i) the temporal (between-day) and contemporaneous (within-day) daily associations between PA and PEs in individuals at different early clinical stages for psychosis and ii) whether these associations differed per clinical stage.METHODS: Daily diary data for 90 days came from 96 individuals at risk for psychosis, distributed over four subgroups defined according to the clinical staging model (stages 0-1b). We constructed multilevel models with PA as a predictor of PEs and vice versa. We investigated within- and between-person temporal and contemporaneous associations and tested whether these associations differed among early stages with multilevel moderation analyses.RESULTS: We found no within-person temporal effects between PA and PEs in either direction. Contemporaneously, current-day PA predicted current-day PEs (B = -0.14,
p < 0.001) and vice versa (B = -0.61,
p < 0.001). Between persons, more 90-day PA predicted fewer PEs in the temporal model (B = -0.14,
p = 0.03). In addition, more 90-day PEs predicted PA in the temporal (B = -0.26,
p < 0.001) and contemporaneous (B = -0.36,
p < 0.001) models. The contemporaneous association between PA and PEs was stronger in individuals at ultra-high risk (UHR) for psychosis than in earlier stages.
DISCUSSION: Our study supported a significant within-day, bidirectional relationship between PA and PEs. This suggests that a focus on PA and methods to improve PA may be an important addition to early intervention practices, particularly in those at UHR for psychosis.
AB - INTRODUCTION: Psychosis often develops gradually along a continuum of severity. Little is known about the role of protective factors such as positive affect (PA) in the development of psychotic experiences (PEs). This study investigated i) the temporal (between-day) and contemporaneous (within-day) daily associations between PA and PEs in individuals at different early clinical stages for psychosis and ii) whether these associations differed per clinical stage.METHODS: Daily diary data for 90 days came from 96 individuals at risk for psychosis, distributed over four subgroups defined according to the clinical staging model (stages 0-1b). We constructed multilevel models with PA as a predictor of PEs and vice versa. We investigated within- and between-person temporal and contemporaneous associations and tested whether these associations differed among early stages with multilevel moderation analyses.RESULTS: We found no within-person temporal effects between PA and PEs in either direction. Contemporaneously, current-day PA predicted current-day PEs (B = -0.14,
p < 0.001) and vice versa (B = -0.61,
p < 0.001). Between persons, more 90-day PA predicted fewer PEs in the temporal model (B = -0.14,
p = 0.03). In addition, more 90-day PEs predicted PA in the temporal (B = -0.26,
p < 0.001) and contemporaneous (B = -0.36,
p < 0.001) models. The contemporaneous association between PA and PEs was stronger in individuals at ultra-high risk (UHR) for psychosis than in earlier stages.
DISCUSSION: Our study supported a significant within-day, bidirectional relationship between PA and PEs. This suggests that a focus on PA and methods to improve PA may be an important addition to early intervention practices, particularly in those at UHR for psychosis.
U2 - 10.3389/fpsyt.2024.1314920
DO - 10.3389/fpsyt.2024.1314920
M3 - Article
C2 - 39267696
SN - 1664-0640
VL - 15
JO - Frontiers in Psychiatry
JF - Frontiers in Psychiatry
M1 - 1314920
ER -